I-Mab logo
I-Mab IMAB

Quarterly report 2025-Q4
added 04-25-2026

report update icon

I-Mab Depreciation & Amortization 2011-2026 | IMAB

Annual Depreciation & Amortization I-Mab

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - 23.9 M 25.3 M 13.8 M 12.7 M 9.8 M 6.7 M 1.6 M - - - - - -

All numbers in CNY currency

Indicator range from annual reports

Maximum Minimum Average
25.3 M 1.6 M 13.4 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
380 K - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.3 M $ 1.63 -4.4 % $ 191 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
5.73 B - - $ 96.9 B britainBritain
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
546 K $ 0.73 -0.03 % $ 33.4 M israelIsrael
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
3.02 M $ 7.83 -5.21 % $ 214 M israelIsrael
Athira Pharma Athira Pharma
ATHA
972 K - - $ 269 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
105 K $ 3.12 - $ 649 M usaUSA
Exelixis Exelixis
EXEL
29.1 M $ 51.1 -0.37 % $ 13.9 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
64 K $ 23.96 -2.84 % $ 310 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
20 K - -32.59 % $ 7.61 M usaUSA
Karyopharm Therapeutics Karyopharm Therapeutics
KPTI
296 K $ 8.9 0.56 % $ 1.08 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
18.4 M $ 4.4 -7.76 % $ 1.31 B canadaCanada
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
31.6 M $ 17.3 -5.57 % $ 809 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
461 K $ 3.03 6.32 % $ 283 M israelIsrael
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
66 K - - $ 231 M usaUSA
Gilead Sciences Gilead Sciences
GILD
370 M $ 132.06 -0.74 % $ 164 B usaUSA
Genprex Genprex
GNPX
6.69 K $ 0.86 1.2 % $ 802 K usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
24 K $ 3.49 -4.12 % $ 5.75 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Fortress Biotech Fortress Biotech
FBIO
403 K $ 2.3 3.14 % $ 64.2 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
700 K $ 21.57 -0.55 % $ 2.74 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
122 K - -11.43 % $ 502 K usaUSA